New Skin Cancer Drug Could Cure Cancer
A new drug has been developed that can block a faulty molecule present in cancer cells, killing the tumorous cells. The drug works at the molecular level, representing a seismic shift in cancer treatment. So far trials have involved just 31 people, however results have been very good.
The research work is being carried out by scientists at the Memorial Sloan-Kettering Hospital in New York.
The drug, PLX4032, blocks the activity of the BRAF gene, which is believed to be the cause of the spread of skin cancer.
However, the drug is only a treatment for skin cancer at the moment, which could prolong life for sufferers. It is not currently capable of curing the condition, although scientists are hopeful that this could one day lead to a cure.
Recommended Reading
• Obesity Cure Is Being Developed
• Exercise Reduces Effects of Obesity Gene
• Deadly new form of MRSA emerges
• Can exercise beat cancer?
• October is Breast Cancer Awareness Month

Tweet Me!







